Skip to main content
Download PDF
Download ePub
  • Research article
  • Open access
  • Published:

Relationship between tracheal intubation and the drugs used by patients with drug overdose due to self-harm

Journal of Pharmaceutical Health Care and Sciences volume 8, Article number: 2 (2022) Cite this article

Abstract

Background

Tracheal intubation may be performed in patients with drug overdose due to self-harm; however, the details of the causative drug are unknown. The purpose of this study was to clarify the relationship between drugs or its blood levels of patients with drug overdose and the need for tracheal intubation based on the actual measurement results.

Methods

From October 2018 to March 2020, 132 patients with drug overdose due to self-harm who were transported to the emergency department (ED) were studied. Patient drugs were measured using gas chromatography–mass spectrometry (GC-MS) and were analyzed on the basis of the GC/MS Forensic Toxicological Database. Logistic analysis was performed by combining patient information and GC-MS information.

Results

The Glasgow Coma Scale (GCS) and Japan Coma Scale (JCS) efficiently predicted tracheal intubation in patients with drug overdose during transport triage; GCS (cut-off value: 12, area under the curve (AUC): 0.81, 95% confidence interval (CI): 0.71–0.88, sensitivity: 0.85, specificity: 0.71, P < 0.05) and JCS (cut-off value: 3, AUC: 0.74, 95% CI: 0.60–0.84, sensitivity: 0.60, specificity: 0.84, P < 0.05). The drugs detected in all patients with drug overdose in order were benzodiazepine receptor agonists (BZs; 43.9%), anticonvulsants (38.6%), antipsychotics (25.0%), and antidepressants (9.8%). In univariate logistic analysis, antipsychotics (odds ratio (OR) 2.46, 95% CI 1.19–5.20, P < 0.05), anticonvulsants (OR 2.71, 95% CI 1.26–5.98, P < 0.05), and anticonvulsants above alert blood levels (OR 27.8, 95% CI 2.92–264.1, P < 0.05) were significantly associated with tracheal intubation in patients with drug overdose, but not BZs and antidepressants. Also, in multivariate logistic analysis, antipsychotics (OR 2.27, 95% CI 1.07–4.83, P < 0.05), anticonvulsants (OR 2.50, 95% CI 1.14–5.64, P < 0.05) and in multivariate logistic analysis of blood levels, anticonvulsants above the alert blood levels (OR 24.9, 95% CI 2.56–241.6, P < 0.05) were significantly associated with tracheal intubation in patients with drug overdose respectively.

Conclusions

Logistic analysis revealed that the use of anticonvulsants and antipsychotics were significantly associated with an increased OR in the tracheal intubation of patients with drug overdose due to self-harm.

Background

Tracheal intubation may be performed in patients with drug overdose due to respiratory failure and central nervous system depression caused by the action of drugs used by these patients [1, 2]. In addition, tracheal intubation is performed for patients with drug overdose due to various factors, such as cardiovascular toxicity and multiple organ failure [3, 4]. Tracheal intubation is important in securing the airway for breathing, but the criteria for tracheal intubation in patients with drug overdose are unclear [1]. There are few reports on drugs requiring tracheal intubation due to overdose. Information on drugs that increase the risk of tracheal intubation in patients with drug overdose may lead to rapidly saving the lives of these patients.

The Glasgow Coma Scale (GCS), which is used for consciousness judgment in the cranial nerves (traumatic brain injury), is used to determine the patient’s status [5, 6]. The GCS is determined by the total E (eye-opening), V (verbal), and M (motor) responses, and is used worldwide [7].

The Japan Coma Scale (JCS) was reported by Dr. Tomio Ohta in 1976 in Japanese as an index for determining the severity of impaired consciousness [8,9,10]. Since JCS uses only eye reactivity as an index to indicate the level of consciousness, it is easier and faster to determine the patient’s level of consciousness compared with GCS. The JCS is scored as 0 (Clear), 1 (Eye-opening spontaneously), 2 (Eye-opening to verbal or pain stimuli), and 3 (No eye-opening to any stimuli) [8, 9]. Also, in a cohort study, JCS is sufficient to predict stroke outcomes [10] and is reported to predict in-hospital mortality upon arrival at the hospital after trauma [11, 12]. However, there are few reports of how drug overdose is associated with GCS or JCS.

A study examined the number of reports from a database that registered self-reported drugs in patients with drug overdose who had tracheal intubation [13, 14]. However, there are no reports that statistically examined the relevance of tracheal intubation using measured values of patient samples. In addition, there are no reports of how gas chromatography–mass spectrometry (GC-MS)-identified drugs in patient samples is associated with the risk of tracheal intubation in patients with drug overdose. The purpose of this study was to measure the drugs or its blood levels of patients with drug overdose, identify the drugs that require tracheal intubation on the basis of logistic analysis, and evaluate the odds ratio (OR). The results obtained may be beneficial for transport triage in the emergency department (ED).

Methods

Patients and study design

From October 2018 to March 2020, 132 patients with drug overdose who were transported to Teikyo University Hospital were studied. The primary endpoint of this retrospective study was tracheal intubation. Patients with drug overdose were defined as patients who were diagnosed with drug overdose by doctors. Blood that were randomly left over at the hospital laboratory and anonymized were used as samples. Blood samples collected immediately after transport were used for the measurement. Psychotropic drugs (benzodiazepine receptor agonists (BZs), antipsychotics, antidepressants, and anticonvulsants) are among the leading causes of patients with drug overdose needing emergency transport [15] and were analyzed in this study. Drugs identified using GC-MS were evaluated. Other patient information was collected from electronic medical records. Information, such as temperature and pulse rate, used in this study was the value at the time of arrival at the hospital. To match the conditions of acquisition timing, there are some missing values (pulse rate, respiratory rate, PO2, time from patient discovery to sample collection and time from patient discovery to transportation). Table 1 specifies the number of defects.

Table 1 Characteristics of patients and GC-MS detected drugs
Full size table

GC-MS

GCMS-QP2020 (Shimadzu, Japan) was used for GC-MS. The column was Rxi-5SilMS 30 m × 0.25 mm (Restek Corporation, U.S.A.), and the upper limit of the column temperature was set to 320 °C. The carrier gas was helium, the MS ion source temperature was 200 °C, and the ionization method was electron ionization. The injection volume was 1 μL.

The GC/MS Forensic Toxicological Database Ver. 1.1 (Shimadzu) was used for data analysis [16]. An example of using this measurement system was previously reported [17]. In more detail, in the GC/MS Forensic Toxicological Database Ver.1.1, the retention time of GC and the fragment information of MS for drugs are registered in advance. The database can simultaneously measure the blood concentrations of 90 drugs semi-quantitatively. Psychiatric drugs and drugs of abuse are registered and are known to cause an overdose. The semi-quantitative analysis method looked for instances where multiple substances were simultaneously detected or when standard substances were rare, and many reports had been made [18,19,20,21,22]. The slope of the calibration curve is required for semi-quantification by this database. When measuring concentrations other than those registered, it is possible to adapt to a simultaneous quantitative system by creating a calibration curve y = ax + b for the target drug by the internal standard method and incorporating “a” (the slope) in the database. More than 500 kinds of drugs are incorporated in the database. Furthermore, the NIST14 library is also incorporated, making it possible to apply any toxicant and simultaneously perform qualitative analysis.

Standards were analyzed on the basis of four or five points (1–30 ppm). Measurement was performed using an internal standard method. Custom Internal Standard (Shimadzu GLC; 4-Chlorotoluene-d4, Acenaphthene-d10, 1, 4-Dichlorobenzene-d4, Fluoranthene-d10, Naphthalene-d8, Chrysene-d12, Phenanthrene-d10, and Perylene-d12) was used as an internal standard substance. The following drugs were used to add quantitative information to the database: Olanzapine, nortriptyline, paroxetine, clonazepam, sertraline, zopiclone, levetiracetam, and lamotrigine. Olanzapine, nortriptyline, paroxetine, levetiracetam, and lamotrigine were purchased from Tokyo Chemical Industry CO., LTD (Japan). Clonazepam and sertraline were purchased from Fujifilm Wako Pure Chemical Corporation (Japan). Zopiclone was purchased from Sigma-Aldrich (U.S.A.). The information of “a” (the slope) obtained were as follows: olanzapine (0.316), nortriptyline (0.571), sertraline (0.11), paroxetine (0.178), zopiclone (0.16), clonazepam (5.50), levetiracetam (0.897), and lamotrigine (0.127). The calibration curves were R2 > 0.99. The data were incorporated into the GC/MS Forensic Toxicological Database. Other drugs were semi-quantified using the preset values in the database.

Pretreatment of patient blood samples and recovery rate of drugs

Patient samples were pretreated for purification before the measurement was performed. QuEChERS (Restek Corporation) and Q-sep dSPE (Restek Corporation) were used for pretreatment. The operation followed the product protocol. Nitrogen was blown to solidify the components. The samples were reconstituted with 50-μL ethyl acetate.

The Custom Internal Standard was set to 1 ppm to make measurement solutions and measured by GC-MS. The loss of pretreatment (QuEChERS-dSPE) was corrected by using the recovery rate of drugs [23].

The alert levels in the blood

The alert levels of drugs in the blood were determined according to the literature [24,25,26]. The alert levels in the blood represent drug concentrations exceeding a certain level, where a significantly increased risk of concentration-related adverse drug reactions can be expected.

Statistical analysis

The logistic regression analysis, receiver operating characteristics (ROC) curve, chi-square test, and Mann–Whitney U test were performed using JMP Pro. 15 (SAS Institute Inc., NC, U.S.A.). The significance level was set at less than 0.05.

Results

Patients and GC-MS-detected drugs

A comparison of the characteristics of each patient groups. Table 1 includes sex, age, GC-MS-detected drugs, GCS, JCS, body temperature, pulse rate, respiratory rate, PO2, time from patient discovery to sample collection and time from patient discovery to transportation. In total, 20 of 132 patients (15.2%) were of tracheal intubation. In the group with tracheal intubation, blood sampling may have been delayed due to various treatments by tracheal intubation. In patients with tracheal intubation, the average age was about 8 years higher than without tracheal intubation group. The drugs detected in all patients with drug overdose in order were BZs (43.9%), anticonvulsants (38.6%), antipsychotics (25.0%), and antidepressants (9.8%). The GC-MS-detected rate of BZs was almost the same with and without tracheal intubation; however, anticonvulsants, antipsychotics, and antidepressants were higher in patients with tracheal intubation.

Although there are some missing values, in patients with tracheal intubation,” time from patient discovery to sample collection” was about 30 min longer on average than in patients without tracheal intubation. The average pulse rate (beats/min) and respiratory rate (breaths/min) were high in patients with tracheal intubation compared with those without tracheal intubation. In addition, average PO2 (mmHg) was higher than the reference value in the group of patients with drug overdose and was remarkable in those with tracheal intubation.

GCS and JCS at transport efficiently predicted tracheal intubation in patients with drug overdose

According to ROC curve analysis, GCS and JCS at transport efficiently predicted tracheal intubation in patients with drug overdose (Fig. 1): (A) Total GCS (cut-off value: 12, area under the curve (AUC): 0.81, 95% confidence interval (CI): 0.71–0.88, sensitivity: 0.85, specificity: 0.71, P < 0.05), E of GCS (cut-off value: 2, AUC: 0.76, 95% CI: 0.63–0.86, sensitivity: 0.70, specificity: 0.79, P < 0.05), V of GCS (cut-off value: 3, AUC: 0.79, 95% CI: 0.68–0.87, sensitivity: 0.75, specificity: 0.74, P < 0.05), M of GCS (cut-off value: 5, AUC: 0.76, 95% CI: 0.63–0.85, sensitivity: 0.75, specificity: 0.76, P < 0.05) and (B) JCS (cut-off value: 3, AUC: 0.74, 95% CI: 0.60–0.84, sensitivity: 0.6, specificity: 0.84, P < 0.05).

Fig. 1
figure 1

ROC curves of GCS and JCS for prediction of the tracheal intubation. A Total GCS (cut-off value: 12, AUC: 0.81, 95% CI: 0.71–0.88, sensitivity: 0.85, specificity: 0.71, P < 0.05) and (B) JCS (cut-off value: 3, AUC: 0.74, 95% CI: 0.60–0.84, sensitivity: 0.6, specificity: 0.84, P < 0.05)

Full size image

Drugs related to tracheal intubation in patients with drug overdose

The univariate analysis revealed that GC-MS-detected antipsychotics (OR 2.46, 95% CI 1.19–5.20, P = 0.01) and anticonvulsants (OR 2.71, 95% CI 1.26–5.98, P = 0.01) were significantly correlated with tracheal intubation of patients with drug overdose (Table 2). However, BZs (OR 0.88, 95% CI 0.48–1.46, P = 0.64) and antidepressants (OR 1.51, 95% CI 0.35–4.89, P = 0.52) were not significant.

Table 2 Association between exposure variables and tracheal intubation
Full size table

Two variables for multivariate analysis were selected from the results of the univariate analysis and the sample size. According to multivariate logistic analysis, GC-MS-detected antipsychotics (OR 2.27, 95% CI 1.07–4.83, P = 0.03) and anticonvulsants (OR 2.50, 95% CI 1.14–5.64, P = 0.02) were significantly correlated with tracheal intubation of patients with drug overdose.

Relationship between tracheal intubation and drug alert blood levels in patients with drug overdose

The alert levels in the blood represent drug concentrations exceeding a certain level, where a significantly increased risk of concentration-related adverse drug reactions can be expected [24,25,26]. We investigated the relationship between reaching alert blood levels and tracheal intubation (Table 3.). The univariate analysis revealed that GC-MS-detected alert levels of antipsychotics (OR 4.04, 95% CI 0.63–25.9, P = 0.14) and anticonvulsants (OR 27.8, 95% CI 2.92–264.1, P = 0.004) in blood were significantly correlated with tracheal intubation of patients with drug overdose (Table 3). However, the alert levels of BZs (OR 0.75, 95% CI 0.23–2.43, P = 0.63) in blood was not significant.

Table 3 Association between exposure variables and tracheal intubation (over the alert levels in blood)
Full size table

Two variables for multivariate analysis were selected from the results of Table 2 and sample size. According to multivariate logistic analysis, GC-MS-detected alert levels of anticonvulsants (OR 24.9, 95% CI 2.56–241.6, P = 0.006) in blood was significantly correlated with tracheal intubation of patients with drug overdose. However, GC-MS-detected alert levels of antipsychotics (OR 2.73, 95% CI 0.32–23.6, P = 0.36) in blood was not significant. Antidepressants were not examined because there was no relevant case.

Discussion

In this study, there are three new findings regarding drugs used by patients with drug overdose due to self-harm requiring tracheal intubation. First, GCS and JCS at transport efficiently predicted tracheal intubation in patients with drug overdose. Second, tracheal intubation and the use of anticonvulsants and anticonvulsants reaching alert blood levels were found to be independently associated with tracheal intubation. The OR was 2.7 times for each type of anticonvulsant taken. Furthermore, it was shown that the OR was 27.8 times higher when anticonvulsants reached alert levels in blood. Third, antipsychotics, which are often used by patients with drug overdose [13, 14, 27, 28], were significantly associated with tracheal intubation, but not when they reached alert blood levels. An overdose of antipsychotics was found to increase the OR for tracheal intubation by 2.5 times. In addition, when multivariate logistic analysis was performed using antipsychotics and anticonvulsants as explanatory variables, the OR for tracheal intubation was 2.3 times higher for antipsychotics and 2.5 times higher for anticonvulsants (for each type). Anticonvulsant drugs included target of therapeutic drug monitoring, such as valproic acid, carbamazepine, and lamotrigine [24,25,26]. From the results of this study, as many of these drugs reached to an alert blood level due to overdose, it was thought that the adverse effects of respiratory inhibition might occur in patients due to excessive central inhibition. As a result, OR for tracheal intubation was considered to be increased compared with other drugs. Tracheal intubation in patients with drug overdose due to self-harm is determined quickly with limited information. Therefore, the results obtained in this study may be useful information to determine drugs that requires tracheal intubation during triage.

Average body temperature (°C) was almost the same in both groups and was normal. Although there are some missing values, average respiratory rate (breaths/min) was 1–2 times higher than the normal value in all patient groups, but it was close to normal. The average pulse rate (beats/min) was high in patients with drug overdose with tracheal intubation. Antidepressants, antipsychotics, and anticonvulsants may act on the heart and cause tachycardia [29, 30], consistent with the drug results in this study. Therefore, it can be considered that tachycardia was stronger in patients requiring tracheal intubation. In addition, average PO2 (mmHg) was higher than the reference value in all patients with drug overdose and was remarkable in patients requiring tracheal intubation. High PO2 levels were considered to be the result of tracheal intubation or oxygen administration with an oxygen mask in the time duration between the site of trauma and arrival at the hospital. These values include the results of on-site ambulance crew treatment. Considering these factors, drug overdose often leads to tracheal intubation due to its influence on the consciousness of the patient. In Japan, tracheal intubation is indicated for patients with impaired consciousness with a GCS of ≤8 and a JCS of ≥2, but there is no regulation for patients with drug overdose. In this study, it was clarified that GCS and JCS during transportation appropriately predicted tracheal intubation. However, tracheal intubation for drug overdose may have been required based on the criteria for impaired consciousness, so it is necessary to consider information on the used drug.

Although previous studies reported frequency as a single used drug, the results of this study are similar in that antipsychotics are used more frequently in tracheal intubated patients [13, 14]. On the other hand, the major difference was that the use of narcotics and stimulants as medications to be taken was small in this study. Reports have stated that the use of narcotics and stimulants is relatively low in Japan [31], which is affirmed in this study. In the past, drug overdose in Japan has been reported to be related to barbituric acid-based drugs as drugs that worsen the clinical course, such as long-term stay in the intensive care unit and aspiration pneumonia [31]. Aspiration pneumonia caused by tracheal intubation may extend the length of hospital stay and, as a result, it is likely to use a lot of medical resources [32, 33]. Therefore, anticonvulsants and antipsychotics, which were found to increase the OR for tracheal intubation by overdose in this study, may also have a risk of worsening the clinical course. In addition, anticonvulsants and antipsychotics have the same lethal toxicity and are extremely dangerous in terms of mortality [34]. Anticonvulsants and antipsychotics are prescribed as treatments for bipolar disorder [35, 36]. From the above, it is considered that a relatively serious condition requiring tracheal intubation may occur, especially for patients with bipolar disorder with an overdose of regular medications. Criteria for tracheal intubation when GCS is ≤8 exist for trauma, but there are no criteria for patients with drug overdose [1]. The results of this study may be included in the criteria for considering the need for tracheal intubation based on the drugs used. Furthermore, in clinical practice, it may be possible to prevent drug overdose by paying attention to the appropriate number of drugs in stock and the use of the drug itself according to the number of prescription days, but verification with a larger sample group is required. Toxicity of anticonvulsants and antipsychotics includes central nervous system depression and cardiotoxicity, which are fatal [30, 37,38,39,40,41]. Some reports stated that meropenem is effective as an antidote for an overdose of sodium valproate [42, 43], and an intravenous injection of lipid emulsion is effective in detoxifying cardiotoxicity due to an overdose of quetiapine [44]. However, neither anticonvulsants nor antipsychotics have a specific antidote, and the treatment is symptomatic. For this reason, overdose with anticonvulsants and antipsychotics may require continuous electrocardiogram measurement of the patient as well as respiratory management after tracheal intubation.

As a limitation of this study, only drugs that can be detected by GC-MS are targeted. Two cases could not be detected; the tracheal intubated patients included overdose with lithium carbonate alone (n = 1) and overdose with ethylene glycol and psychotropic drugs (n = 1) in this study. Ideally, other methods should be combined for the optimal treatment of patients with drug overdose. In addition, in this study, we only investigated each drug category, such as antipsychotics and anticonvulsants. How individual drugs in the drug category are associated with tracheal intubation could not be investigated due to the small number of cases. Although the data of this study is a single result immediately after transport, drug blood levels may be used for on-site triage because they adequately indicate clinical severity [26]. However, it should be noted that differences in the dynamics of individual drugs, such as Tmax and T1/2, are not taken into consideration. For proper treatment, fluctuations in blood levels should be monitored after arrival at the hospital. Since it was a single-institutional result, local community may affect the result. Finally, this study only examined the level of consciousness based on GCS and JCS to what extent each drug influenced patients. Since individual drugs may have different effects on the cranial nerve system and organs, the drugs taken in individual cases should also be considered for appropriate treatment.

Conclusions

In this study, logistic analysis revealed that the use of anticonvulsants and antipsychotics is significantly associated with an increased OR in the tracheal intubation of patients with drug overdose due to self-harm. The results obtained may be beneficial for the transport triage in the ED.

Availability of data and materials

The datasets that are either or both used and analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

GCS:

Glasgow coma scale

JCS:

Japan coma scale

BZs:

benzodiazepine receptor agonists

GC-MS:

gas chromatography–mass spectrometry

ED:

emergency department

ROC:

receiver operating characteristic

AUC:

Area under the curve

CI:

Confidence interval

OR:

Odds ratio

References

  1. Duncan R, Thakore S. Decreased Glasgow coma scale score does not mandate endotracheal intubation in the emergency department. J Emerg Med. 2009;37(4):451–5. https://doi.org/10.1016/j.jemermed.2008.11.026.

    Article  PubMed  Google Scholar 

  2. Adnet F, Borron SW, Finot MA, Lapandry C, Baud FJ. Intubation difficulty in poisoned patients: association with initial Glasgow coma scale score. Acad Emerg Med. 1998;5(2):123–7. https://doi.org/10.1111/j.1553-2712.1998.tb02596.x.

    Article  CAS  PubMed  Google Scholar 

  3. Unverir P, Atilla R, Karcioglu O, Topacoglu H, Demiral Y, Tuncok Y. A retrospective analysis of antidepressant poisonings in the emergency department: 11-year experience. Hum Exp Toxicol. 2006;25(10):605–12. https://doi.org/10.1177/096032706072470.

    Article  CAS  PubMed  Google Scholar 

  4. Burket GA, Horowitz BZ, Hendrickson RG, Beauchamp GA. Endotracheal intubation in the pharmaceutical-poisoned patient: a narrative review of the literature. J Med Toxicol. 2021;17(1):61–9. https://doi.org/10.1007/s13181-020-00779-3.

    Article  PubMed  Google Scholar 

  5. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81–4. https://doi.org/10.1016/s0140-6736(74)91639-0.

    Article  CAS  PubMed  Google Scholar 

  6. Jennett B, Teasdale G. Aspects of coma after severe head injury. Lancet. 1977;1(8017):878–81. https://doi.org/10.1016/s0140-6736(77)91201-6.

    Article  CAS  PubMed  Google Scholar 

  7. Graham T, Andrew M, Fiona L, Geoffrey M, Nino S, Gordon M. The Glasgow coma scale at 40 years: standing the test of time. Lancet Neurol. 2014;13(8):844–54. https://doi.org/10.1016/S1474-4422(14)70120-6.

    Article  Google Scholar 

  8. Ohta T. Severity criteria for impaired consciousness. (In Japanese) Clinic All-Round. 1985;34:477–82.

    Google Scholar 

  9. Ohta T, Waga S, Handa H, Saitoh I, Takeuchi K, Suzuki J, et al. Draft new classification of consciousness disorders—possibility of quantitative expression (Group III: 3-stage method). (In Japanese) Neurol Surg. 1974:623–7.

  10. Shigematsu K, Nakano H, Watanabe Y. The eye response test alone is sufficient to predict stroke outcome--reintroduction of Japan coma scale: a cohort study. BMJ Open. 2013;3(4):e002736. https://doi.org/10.1136/bmjopen-2013-002736.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Yumoto T, Naito H, Yorifuji T, Aokage T, Fujisaki N, Nakao A. Association of Japan Coma Scale score on hospital arrival with in-hospital mortality among trauma patients. BMC Emerg Med. 2019;19(1):65. https://doi.org/10.1186/s12873-019-0282-x.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Okada Y, Kiguchi T, Iiduka R, Ishii W, Iwami T, Koike K. Association between the Japan coma scale scores at the scene of injury and in-hospital outcomes in trauma patients: an analysis from the nationwide trauma database in Japan. BMJ Open. 2019;9(7):e029706. https://doi.org/10.1136/bmjopen-2019-029706.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Beauchamp GA, Hendrickson RG, Hatten BW, Toxicology Investigators Consortium (ToxIC). Endotracheal intubation for toxicologic exposures: A retrospective review of Toxicology Investigators Consortium (ToxIC) Cases. J Emerg Med. 2016;51:382–8.e11.

    Article  Google Scholar 

  14. Beauchamp GA, Giffin SL, Horowitz BZ, Laurie AL, Fu R, Hendrickson RG. Poisonings associated with intubation: US National Poison Data System Exposures 2000-2013. J Med Toxicol. 2016;12(2):157–64. https://doi.org/10.1007/s13181-015-0528-2.

    Article  CAS  PubMed  Google Scholar 

  15. Okumura Y, Tachimori H, Matsumoto T, Nishi D. Exposure to psychotropic medications prior to overdose: a case-control study. Psychopharmacology. 2015;232(16):3101–9. https://doi.org/10.1007/s00213-015-3952-8.

    Article  CAS  PubMed  Google Scholar 

  16. GC/MS Forensic Toxicological Database: Shimadzu Corporation. https://www.shimadzu.com/an/literature/gcms/jpo212153.html. Accessed 1 Sep 2021.

  17. Imanaka S, Kuwabara T, Nagashima K, Enomoto H, Onuki T, Kaneko I, et al. Status and issues of instrumental analysis for toxic substances in emergency intensive care unit. (in Japanese) J Jpn Soc Emerg Med. 2020;23:711–6.

    Google Scholar 

  18. Gunnar T, Mykkänen S, Ariniemi K, Lillsunde P. Validated semiquantitative/quantitative screening of 51 drugs in whole blood as silylated derivatives by gas chromatography-selected ion monitoring mass spectrometry and gas chromatography electron capture detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;806(2):205–19. https://doi.org/10.1016/j.jchromb.2004.04.005.

    Article  CAS  PubMed  Google Scholar 

  19. Paterson S, Cordero R, Burlinson S. Screening and semi-quantitative analysis of post mortem blood for basic drugs using gas chromatography/ion trap mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;813(1-2):323–30. https://doi.org/10.1016/j.jchromb.2004.10.036.

    Article  CAS  PubMed  Google Scholar 

  20. Zushi Y, Hashimoto S, Tamada M, Masunaga S, Kanai Y, Tanabe K. Retrospective analysis by data processing tools for comprehensive two-dimensional gas chromatography coupled to high resolution time-of-flight mass spectrometry: a challenge for matrix-rich sediment core sample from Tokyo Bay. J Chromatogr A. 2014;1338:117–26. https://doi.org/10.1016/j.chroma.2014.02.015.

    Article  CAS  PubMed  Google Scholar 

  21. Zdravkovic SA, Duong CT, Hellenbrand AA, Duff SR, Dreger AL. Establishment of a reference standard database for use in the qualitative and semi-quantitative analysis of pharmaceutical contact materials within an extractables survey by GC-MS. J Pharm Biomed Anal. 2018;151:49–60. https://doi.org/10.1016/j.jpba.2017.12.054.

    Article  CAS  PubMed  Google Scholar 

  22. Sekine Y, Sato S, Kimura K, Sato H, Nakai S, Yanagisawa Y. Detection of tobacco smoke emanating from human skin surface of smokers employing passive flux sampler - GCMS system. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1092:394–401. https://doi.org/10.1016/j.jchromb.2018.06.038.

    Article  CAS  PubMed  Google Scholar 

  23. Kusano M, Sakamoto Y, Natori Y, Miyagawa H, Tsuchihashi H, Ishii A, et al. Development of “quick-DB forensic”: a total workflow from QuEChERS-dSPE method to GC-MS/MS quantification of forensically relevant drugs and pesticides in whole blood. Forensic Sci Int. 2019;300:125–35. https://doi.org/10.1016/j.forsciint.2019.03.048.

    Article  CAS  PubMed  Google Scholar 

  24. Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51(1-02):9–62. https://doi.org/10.1055/s-0043-116492.

    Article  CAS  PubMed  Google Scholar 

  25. Schoretsanitis G, Paulzen M, Unterecker S, Schwarz M, Conca A, Zernig G, et al. TDM in psychiatry and neurology: a comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians. World J Biol Psychiatry. 2018;19(3):162–74. https://doi.org/10.1080/15622975.2018.1439595.

    Article  PubMed  Google Scholar 

  26. Schulz M, Schmoldt A, Andresen-Streichert H, Iwersen-Bergmann S. Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics. Crit Care. 2020;24(1):195. https://doi.org/10.1186/s13054-020-02915-5.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Mainio A, Kuusisto L, Hakko H, Riipinen P. Antipsychotics as a method of suicide: population-based follow-up study of suicide in northern Finland. Nord J Psychiatry. 2021;75(4):281–5. https://doi.org/10.1080/08039488.2020.1847323.

    Article  PubMed  Google Scholar 

  28. Methling M, Krumbiegel F, Hartwig S, Parr MK, Tsokos M. Toxicological findings in suicides – frequency of antidepressant and antipsychotic substances. Forensic Sci Med Pathol. 2019;15(1):23–30. https://doi.org/10.1007/s12024-018-0041-4.

    Article  CAS  PubMed  Google Scholar 

  29. Vieweg WV, Wood MA, Fernandez A, Beatty-Brooks M, Hasnain M, Pandurangi AK. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly. Drugs Aging. 2009;26(12):997–1012. https://doi.org/10.2165/11318880-000000000-00000.

    Article  CAS  PubMed  Google Scholar 

  30. Patel AR, Nagalli S. Valproate Toxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2021 https://www.ncbi.nlm.nih.gov/books/NBK560898/. Accessed 1 Sep 2021.

  31. Ichikura K, Okumura Y, Takeuchi T. Associations of adverse clinical course and ingested substances among patients with deliberate drug poisoning: a cohort study from an intensive care unit in Japan. PLoS One. 2016;11(8):e0161996. https://doi.org/10.1371/journal.pone.0161996.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Perren A, Brochard L. Managing the apparent and hidden difficulties of weaning from mechanical ventilation. Intensive Care Med. 2013;39(11):1885–95. https://doi.org/10.1007/s00134-013-3014-9.

    Article  PubMed  Google Scholar 

  33. Dodek P, Keenan S, Cook D, Heyland D, Jacka M, Hand L, et al. Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med. 2004;141(4):305–13. https://doi.org/10.7326/0003-4819-141-4-200408170-00011.

    Article  PubMed  Google Scholar 

  34. Ferrey AE, Geulayov G, Casey D, Wells C, Fuller A, Bankhead C, et al. Relative toxicity of mood stabilisers and antipsychotics: case fatality and fatal toxicity associated with self-poisoning. BMC Psychiatry. 2018 Dec 27;18(1):399. https://doi.org/10.1186/s12888-018-1993-3.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D. Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy. Acta Psychiatr Scand. 2007;115(1):12–20. https://doi.org/10.1111/j.1600-0447.2006.00912.x.

    Article  CAS  PubMed  Google Scholar 

  36. Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry. 2007;64(4):442–55. https://doi.org/10.1001/archpsyc.64.4.442.

    Article  CAS  PubMed  Google Scholar 

  37. Chavez P, Dominguez AC, Herzog E. Evolving electrocardiographic changes in lamotrigine overdose: a case report and literature review. Cardiovasc Toxicol. 2015;15(4):394–8. https://doi.org/10.1007/s12012-014-9300-0.

    Article  PubMed  Google Scholar 

  38. Khalili ALK, Sekhon S, Jain S. Carbamazepine toxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2021. https://www.ncbi.nlm.nih.gov/books/NBK507852/. Accessed 1 Sep 2021.

  39. Chue P, Singer P. A review of olanzapine-associated toxicity and fatality in overdose. J Psychiatry Neurosci. 2003;28(4):253–61.

    PubMed  PubMed Central  Google Scholar 

  40. Peridy E, Hamel JF, Rolland AL, Gohier B, Boels D. Quetiapine poisoning and factors influencing severity. J Clin Psychopharmacol. 2019;39(4):312–7. https://doi.org/10.1097/JCP.0000000000001053.

    Article  CAS  PubMed  Google Scholar 

  41. Farkas AN, Marcott M, Yanta JH, Pizon AF. Bicarbonate refractory QRS prolongation and left bundle-branch block following escitalopram and lamotrigine overdose: a case report and literature review of toxic left bundle-branch block. J Clin Pharm Ther. 2018;43(5):717–22. https://doi.org/10.1111/jcpt.12698.

    Article  CAS  PubMed  Google Scholar 

  42. Dreucean D, Beres K, McNierney-Moore A, Gravino D. Use of meropenem to treat valproic acid overdose. Am J Emerg Med. 2019;37:2120.e5–7.

    Article  Google Scholar 

  43. Thomas C, Priano J, Smith TL. Meropenem as an antidote for intentional valproic acid overdose. Am J Emerg Med. 2020;38:690.e1–2.

    Article  Google Scholar 

  44. Bartos M, Knudsen K. Use of intravenous lipid emulsion in the resuscitation of a patient with cardiovascular collapse after a severe overdose of quetiapine. Clin Toxicol (Phila). 2013;51(6):501–4. https://doi.org/10.3109/15563650.2013.803229.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Mr. Sakai for the statistics consultation and Enago for the English language editing.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Laboratory of Clinical Pharmaceutics, Faculty of Pharma-Science, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605, Japan

    Kazuki Nagashima, Hiroyuki Hosono & Machiko Watanabe

Authors
  1. Kazuki Nagashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroyuki Hosono
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Machiko Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

KN measured patient samples using GC-MS. HH collected patient samples. KN statistically analyzed the data and wrote the paper. MW supervised the study and revised the paper. All authors read and revised the manuscript and accepted the submission. The author(s) read and approved the final manuscript.

Corresponding authors

Correspondence to Kazuki Nagashima or Machiko Watanabe.

Ethics declarations

Ethics approval and consent to participate

We excluded personally identifiable information from our research. This study was performed with the approval of the Teikyo University Medical Research Ethics Committee (No. 18–121–2). This is a retrospective study using the residual sample of medical treatment. It was decided that informed consent was unnecessary because samples and information were anonymized and could not be identified by individuals.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nagashima, K., Hosono, H. & Watanabe, M. Relationship between tracheal intubation and the drugs used by patients with drug overdose due to self-harm. J Pharm Health Care Sci 8, 2 (2022). https://doi.org/10.1186/s40780-021-00234-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40780-021-00234-7

Keywords

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us